NO891587D0 - Fremgangsmaate for fremstilling av proteinholdige materiale ved dyrking av celler som inneholder rekombinante avipoxvirusvektorer. - Google Patents

Fremgangsmaate for fremstilling av proteinholdige materiale ved dyrking av celler som inneholder rekombinante avipoxvirusvektorer.

Info

Publication number
NO891587D0
NO891587D0 NO891587A NO891587A NO891587D0 NO 891587 D0 NO891587 D0 NO 891587D0 NO 891587 A NO891587 A NO 891587A NO 891587 A NO891587 A NO 891587A NO 891587 D0 NO891587 D0 NO 891587D0
Authority
NO
Norway
Prior art keywords
avipox virus
procedure
preparation
culturing cells
cells containing
Prior art date
Application number
NO891587A
Other languages
English (en)
Other versions
NO891587L (no
Inventor
Friedrich Dorner
Walter Bodemer
Falko Guenther Falkner
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of NO891587D0 publication Critical patent/NO891587D0/no
Publication of NO891587L publication Critical patent/NO891587L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6429—Thrombin (3.4.21.5)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/647—Blood coagulation factors not provided for in a preceding group or according to more than one of the proceeding groups
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21005—Thrombin (3.4.21.5)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO89891587A 1988-04-19 1989-04-18 Fremgangsmaate for fremstilling av proteinholdig materialeved dyrking av celler som inneholder rekombinante avipoxvirusvektorer. NO891587L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3813093A DE3813093A1 (de) 1988-04-19 1988-04-19 Rekombinantes plasmid, verfahren zum herstellen eines rekombinanten avipoxvirus, rekombinantes avipoxvirus und dessen verwendung

Publications (2)

Publication Number Publication Date
NO891587D0 true NO891587D0 (no) 1989-04-18
NO891587L NO891587L (no) 1989-10-20

Family

ID=6352368

Family Applications (1)

Application Number Title Priority Date Filing Date
NO89891587A NO891587L (no) 1988-04-19 1989-04-18 Fremgangsmaate for fremstilling av proteinholdig materialeved dyrking av celler som inneholder rekombinante avipoxvirusvektorer.

Country Status (7)

Country Link
EP (1) EP0338807B1 (no)
JP (1) JPH02131593A (no)
AT (1) ATE129747T1 (no)
DE (2) DE3813093A1 (no)
DK (1) DK175989A (no)
FI (1) FI891848A (no)
NO (1) NO891587L (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5833975A (en) * 1989-03-08 1998-11-10 Virogenetics Corporation Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence
US7045313B1 (en) 1982-11-30 2006-05-16 The United States Of America As Represented By The Department Of Health And Human Services Recombinant vaccinia virus containing a chimeric gene having foreign DNA flanked by vaccinia regulatory DNA
FR2632863B2 (fr) * 1987-10-29 1990-08-31 Transgene Sa Virus du fowlpox recombinant et vaccins derives de ces virus
US5093258A (en) * 1988-08-26 1992-03-03 Therion Biologics Corporation Recombinant fowlpox virus and recombination vector
HUT63459A (en) * 1990-01-26 1993-08-30 Immuno Ag Blood factors produced by recommbinant process, process for expressing them, as well as recombinant vaccine viruses used in the process
MY109299A (en) * 1990-08-15 1996-12-31 Virogenetics Corp Recombinant pox virus encoding flaviviral structural proteins
US5514375A (en) * 1990-08-15 1996-05-07 Virogenetics Corporation Flavivirus recombinant poxvirus vaccine
DK0538496T3 (da) * 1991-08-26 2004-02-23 Baxter Healthcare Sa Rekombinant fjerkrækoppevirus med intakt FPV tk-gen
US5925358A (en) * 1993-02-26 1999-07-20 Syntro Corporation Recombinant fowlpox viruses and uses thereof
US6136318A (en) * 1993-02-26 2000-10-24 Cochran; Mark D. Recombinant fowlpox viruses and uses thereof
AU696247B2 (en) * 1993-02-26 1998-09-03 Syntro Corporation Recombinant fowlpox viruses and uses thereof
EP0753581A1 (en) 1995-07-10 1997-01-15 Immuno Ag Improved recombinant eukaryotic cytoplasmic viruses, method for their production and their use as vaccines
JP7350716B2 (ja) * 2018-03-27 2023-09-26 森永乳業株式会社 微生物の細胞及び／又はウイルスの測定方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2563434B1 (fr) * 1984-04-25 1986-07-25 Transgene Sa Vaccin contre la rage et procede pour sa preparation
WO1985005376A1 (fr) * 1984-05-22 1985-12-05 Transgene S.A. Vecteurs d'expression du facteur ix et lignees cellulaires produisant le facteur ix actif
US5032520A (en) * 1985-03-29 1991-07-16 National Research Development Corporation DNA sequences encoding infectious bronchitis virus spike protein
EP0243029A1 (en) * 1986-04-08 1987-10-28 THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce Recombinant vaccinia virus expressing human retrovirus gene
WO1988002022A1 (en) * 1986-09-22 1988-03-24 Commonwealth Scientific And Industrial Research Or Recombinant poxviruses
JP2531729B2 (ja) * 1987-03-27 1996-09-04 日本ゼオン株式会社 組み換えアビポックスウイルス
EP0284416B1 (en) * 1987-03-27 1995-02-22 Nippon Zeon Co., Ltd. Recombinant avipoxyvirus
DE10399031I1 (de) * 1987-08-28 2004-01-29 Health Research Inc Rekombinante Viren.
CA1340203C (en) * 1987-09-16 1998-12-15 Noboru Yanagida Recombinant apivoxvirus
JP2638622B2 (ja) * 1987-09-16 1997-08-06 日本ゼオン株式会社 組み換えアビポックスウイルス
GB2220941B (en) * 1988-06-24 1991-09-11 Nat Res Dev Fowlpox virus non-essential regions

Also Published As

Publication number Publication date
DK175989A (da) 1989-10-20
DE68924664T2 (de) 1996-04-25
DE68924664D1 (de) 1995-12-07
FI891848A (fi) 1989-10-20
DE3813093A1 (de) 1989-11-09
ATE129747T1 (de) 1995-11-15
EP0338807A2 (en) 1989-10-25
EP0338807A3 (en) 1990-09-12
FI891848A0 (fi) 1989-04-18
JPH02131593A (ja) 1990-05-21
EP0338807B1 (en) 1995-11-02
DK175989D0 (da) 1989-04-12
NO891587L (no) 1989-10-20

Similar Documents

Publication Publication Date Title
NO891587D0 (no) Fremgangsmaate for fremstilling av proteinholdige materiale ved dyrking av celler som inneholder rekombinante avipoxvirusvektorer.
AU2774389A (en) Recombinant vaccinia virus mva
KR920701434A (ko) 박테리아 및 이스트 내에서의 헤모글로빈 및 그의 동족체의 제조방법
ATE172496T1 (de) Wirt-vektor system zur anwendung in gentherapie
DK257984A (da) Fremgangsmaade til fremstilling af en rekombinant baculovirus-udtrykkelsesvektor
AU3069889A (en) Pox virus vectors
ATE366814T1 (de) Gl50 moleküle, sowie verwendungen derselben
IE831211L (en) Cloning vectors for expression of exogenous protein
DE3751632D1 (de) Expression von biologisch-aktiven PDGF-Analogen in eukaryotischen Zellen
KR960701899A (ko) 인자 viii:c활성을 갖는 단백질 복합체 및 그의 제조
DK175843B1 (da) Polypeptider af overfladeaktive alvelolarproteiner (ASP), farmaceutisk sammensætning indeholdende polypeptidet, DNA-ekspressionssystem der koder for polypeptidet, samt fremgangsmåde til fremstilling af polypeptider med ASP-aktivitet
NO177540C (no) Fremgangsmåte for fremstilling av heterologe proteiner i Bombyx mori samt plasmid og rekombinant Bombyx mori nukleært polyhedrosevirus (BmNPV)
DK192189D0 (da) Polypeptid, fremgangsmaade til inhibering af fibrinogen, fremgangsmaade til rensning af et polypeptid, gen indeholdende rekombinante dna kodende for et polypeptid, vektor, cellekultur og fremgangsmaade til fremstilling af et cysteinrigt polypeptid
PT744891E (pt) Fibrinogénio transgénico
EP0397560A3 (en) Spheroidin dna isolate and recombinant entomopoxvirus expression vectors
GB2303137A (en) Sv40-derived dna constructs comprising exogenous dna sequences
DE59712771D1 (de) Nebenhoden-spezifisches Rezeptorprotein und dessen Verwendung
DE68917349D1 (de) Defektives rekombinantes Retrovirus, seine Verwendung zur Integration von Proteine codierenden Sequenzen im Genom von Gewebekulturen, infizierbar mit dem entsprechenden Wildretrovirus, und DNS zur Herstellung dieses rekombinanten Retrovirus.
WO1993025682A3 (en) Chimeric receptor polypeptides, human h13 proteins and uses thereof
FI882238A (fi) Foerbaettringar i samband med organiska foereningar
ES2091179T3 (es) Fragmentos de adn de replicacion autonoma, derivados de celulas de mamiferos y que tienen una afinidad respecto a las proteinas que se fijan en el adn.
ES2064391T3 (es) Adn que codifica un polipeptido anticoagulante.
ATE105864T1 (de) Rekombinante plasmide, die zur expression von heterologen proteinen in bacillus verwendet werden können.
ATE320502T1 (de) Für eine glutamat-dekarboxylase-aktivität kodierende rekombinierende viren
JPS6486876A (en) Variant human lysozyme